148 related articles for article (PubMed ID: 25219743)
1. Primary thyroid marginal zone B-cell lymphoma in a patient with psoriatic arthritis treated with etanercept.
Jin H; Cho HH; Kim WJ; Mun JH; Song M; Kim HS; Ko HC; Kim MB; Kim BS
J Am Acad Dermatol; 2014 Oct; 71(4):e152-3. PubMed ID: 25219743
[No Abstract] [Full Text] [Related]
2. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
Paul C; Solignac M
Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
[No Abstract] [Full Text] [Related]
3. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
Yamauchi PS; Gindi V; Lowe NJ
Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
Mazzotta A; Esposito M; Costanzo A; Chimenti S
Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
[TBL] [Abstract][Full Text] [Related]
5. Efficacy, effectiveness and safety of etanercept in monotherapy for refractory psoriatic arthritis: a 26-week observational study.
de Vlam K; Lories RJ
Rheumatology (Oxford); 2006 Mar; 45(3):321-4. PubMed ID: 16234275
[TBL] [Abstract][Full Text] [Related]
6. [Therapy of psoriasis vulgaris and psoriatic arthritis with etanercept].
Mrowietz U; Barth J; Boehncke WH; Rosenbach T; Wozel G
J Dtsch Dermatol Ges; 2005 Jun; 3(6):470-2. PubMed ID: 15892851
[No Abstract] [Full Text] [Related]
7. Etanercept monotherapy for a patient with psoriasis, psoriatic arthritis, and concomitant hepatitis C infection.
Rokhsar C; Rabhan N; Cohen SR
J Am Acad Dermatol; 2006 Feb; 54(2):361-2. PubMed ID: 16443079
[No Abstract] [Full Text] [Related]
8. Enbrel (etanercept).
Abramovits W; Arrazola P; Gupta AK
Skinmed; 2004; 3(6):333-5. PubMed ID: 15538082
[No Abstract] [Full Text] [Related]
9. Etanercept for psoriasis in the pediatric population: experience in nine patients.
Hawrot AC; Metry DW; Theos AJ; Levy ML
Pediatr Dermatol; 2006; 23(1):67-71. PubMed ID: 16445417
[TBL] [Abstract][Full Text] [Related]
10. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
[TBL] [Abstract][Full Text] [Related]
11. Etanercept for the treatment of psoriasis: combination therapy with other modalities.
Strober BE; Clarke S
J Drugs Dermatol; 2004; 3(3):270-2. PubMed ID: 15176161
[TBL] [Abstract][Full Text] [Related]
12. Etanercept therapy in patients with autoimmunity and hepatitis C.
Khanna M; Shirodkar MA; Gottlieb AB
J Dermatolog Treat; 2003 Dec; 14(4):229-32. PubMed ID: 14660270
[TBL] [Abstract][Full Text] [Related]
13. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
[TBL] [Abstract][Full Text] [Related]
14. When there is no single best biological agent: psoriasis and psoriatic arthritis in the same patient responding to two different biological agents.
Adişen E; Karaca F; Gürer MA
Clin Exp Dermatol; 2008 Mar; 33(2):164-6. PubMed ID: 18257837
[TBL] [Abstract][Full Text] [Related]
15. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
Kitamura G; Mehr N; Anderson N; Sirichotiratana M
Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028
[TBL] [Abstract][Full Text] [Related]
16. Etanercept in the treatment of psoriasis and psoriatic arthritis with concomitant hepatitis C virus infection: clinical and virological study in three patients.
Zanni M; Missale G; Santilli D; Di Nuzzo S
Eur J Dermatol; 2011; 21(4):564-7. PubMed ID: 21543290
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with etanercept of von Zumbusch pustular psoriasis in a patient with human immunodeficiency virus.
Mikhail M; Weinberg JM; Smith BL
Arch Dermatol; 2008 Apr; 144(4):453-6. PubMed ID: 18427038
[No Abstract] [Full Text] [Related]
18. Puerto Rico psoriasis study group: efficacy and safety of etanercept.
González-Chavez JR; Berlingeri-Ramos AC; Sánchez Casiano MA
J Drugs Dermatol; 2005; 4(6):735-9. PubMed ID: 16302559
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
[TBL] [Abstract][Full Text] [Related]
20. Etanercept, childhood and long-term safety: a case of five years treatment.
Mazzotta A; Saraceno R; Esposito M; Chimenti S
Eur J Dermatol; 2011; 21(5):776-7. PubMed ID: 21697062
[No Abstract] [Full Text] [Related]
[Next] [New Search]